Associated Press Release
MIAMI (AP) -- A South Florida company is voluntarily recalling weight loss supplements called "JaDera" and "Xiyouji Qingzhi."
Florida Dolphin Intertrade Corp. announced Friday that these products have been found to contain undeclared Sibutramine, which was a previously approved controlled substance for the treatment of obesity. It was removed from the U.S. market in October 2010 for safety reasons.
Florida Dolphin Intertrade says that products containing Sibutramine are known to substantially increase blood pressure and pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. These products may also interact in life threatening ways with other medications a consumer may be taking.
The company has not received any reports of adverse events related to this recall.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.